An early diagnosis, for example, of KS, in which the mainstay of treatment is based on the minimization of the immunosuppression and treatment with an mTOR inhibitor, could be fundamental to treating cancer but also avoid graft rejection. The gene discussed is MTOR; the disease is cancer.